M

Medical Excellence Capital, LLC

6 employees

Medical Excellence Capital is an early stage life sciences fund.

Investor insights

Sectors invested in

Biotechnology5

Medical3

Biopharma2

Health Care2

Pharmaceutical2

Therapeutics2

Genetics1

Health Diagnostics1

Life Science1

Genomics1

Regenerative Medicine1

biotech1

Cell Therapy1

bioinformatics1

Stem Cells1

IPSCs1

Induced Pluripotent Stem Cells1

Neuroscience1

San Diego1

Parkinson's Disease1

Funding rounds participated in

$58M sweet spot round size

Most of their 5 investments are in rounds between $15M and $61M

Basic info

Industry

venture capital and private equity principals

Sectors

synthetic biology

Biotechnology

venture capital

cell therapy

regenerative medicine

gene therapy

life sciences

academic research

pharmaceuticals

Date founded

2020

Investments made

A

Avilar Therapeutics raised $15M on February 16, 2023

Investors: Sanofi Ventures, Astellas Venture Capital L.L.C., RA Capital Management, L.P. and Medical Excellence Capital, LLC

S

SonoThera raised $61M on December 5, 2022

Investors: Formic Ventures, Illumina Ventures, Foothill Ventures, Vertex Ventures HC, ARCH Venture Partners, Wilson Sonsini Goodrich & Rosati and Medical Excellence Capital, LLC

P

Pleno Inc. raised $15M on May 25, 2022

Investors: Medical Excellence Capital, LLC

A

Aspen Neuroscience, Inc. raised $148M on May 9, 2022

Investors: LYFE Capital, NS Investment, Newton Investment Management, Lifeforce Capital, OrbiMed Advisors, GV, Section 32, Revelation Partners and Medical Excellence Capital, LLC

I

Immunitas Therapeutics raised $58M on August 18, 2021

Investors: NS Investment, M Ventures, The Leukemia & Lymphoma Society, Solasta Ventures, Mirae Asset MAPS Global Investments Co., Ltd, Longwood Fund and Medical Excellence Capital, LLC